Second judge upholds Medicare drug price negotiation program

© Reuters. FILE PHOTO: Pharmaceutical tablets and capsules are arranged in the shape of a U.S. dollar sign on a table in this picture illustration taken in Ljubljana August 20, 2014. REUTERS/Srdjan Zivulovic/File Photo

By Brendan Pierson

(Reuters) – A federal judge in Delaware on Friday upheld a law that requires some drugmakers to negotiate prices with Medicare, one of President Joe Biden’s signature initiatives, rejecting a challenge by AstraZeneca (NASDAQ:).

The decision from U.S. District Judge Colm Connolly comes as AstraZeneca is due to respond to the Biden administration’s initial bid for the price of its blockbuster diabetes drug Farxiga. It is the second time the negotiation program has survived a court challenge.


Leave a Comment